This product is made using the same ingredients as the active ingredient of ibuprofen. Each capsule is made to provide a different dose of medication. The active ingredient in ibuprofen is called ibuprofen and is used to treat pain, fever, inflammation, and swelling.
Do not use if you are allergic to ibuprofen or any other ingredient of this product. Do not exceed the stated dose of ibuprofen in a 24 hour period. Do not use if you have a stomach ulcer, perforation, bleeding or allergic reaction to ibuprofen, other NSAIDs, or if you are taking any other medicines, including capsules, tablets, liquid, and foods. Do not use if you are allergic to ibuprofen. Do not give this product to children under 12 years of age. Do not use if you are pregnant, or nursing.
The information provided here is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk to your healthcare professional for any medical conditions or seek the advice of your doctor or other qualified healthcare provider about other health conditions.
Do not use this product if you are pregnant. Do not use if you are breastfeeding. Do not use if you are pregnant or breastfeeding without consulting your doctor.
A new study shows people who use nonsteroidal anti-inflammatory drugs (NSAIDs) may be less likely to develop a heart attack or other symptoms of heart problems.
The study was funded by a British Heart Foundation, the British Association for Cardiovascular Disease, the Royal College of Surgeons of Great Britain and the British Heart Foundation, the American Heart Association, the British Thoracic Society and the British Association of Cardiovascular Research.
The study, reported in the journalJAMA Internal Medicine, found that use of NSAIDs such as aspirin or ibuprofen can lead to an increased risk of having a heart attack or a stroke that has occurred after a heart attack in people who used the drug for one year.
The researchers also found that taking NSAIDs such as naproxen can lead to a heart attack or stroke that has not occurred previously.
The authors, from the British Heart Foundation, said the results were the first to show that the risk of having a heart attack or stroke increased in people who used non-steroidal anti-inflammatory drugs (NSAIDs) for one year.
"We also found that the risk of having a heart attack or stroke increased in people who used NSAIDs for one year," said Dr. Paul G. H. Wilson, M. D., a professor of cardiovascular medicine at the University of Toronto and director of the Heart Institute, the American Heart Association, the British Heart Foundation, the American Association of Clinical Oncology and the American College of Clinical Oncology.
The risk of having a heart attack or stroke increased in people who used non-steroidal anti-inflammatory drugs for one year
The researchers said their findings were consistent with previous research that showed that people who used NSAIDs for one year had an increased risk of having a heart attack or stroke.
"This study highlights that it may be possible to treat these patients with nonsteroidal anti-inflammatory drugs, and that it may be possible to treat these patients with nonsteroidal anti-inflammatory drugs," said Dr. Gail G. D., director of the Heart Institute, the American Heart Association, the British Heart Foundation, the British Association of Cardiovascular Disease, the American Thoracic Society and the American College of Clinical Oncology.
The study was funded by a British Heart Foundation, the British Association for Cardiovascular Disease, the Royal College of Surgeons of Great Britain and the British Thoracic Society.
In addition to Dr. Wilson, the authors said there were other studies that have shown that use of NSAIDs for one year can cause a higher risk of heart attack and a lower risk of having a heart attack or stroke.
"This was the first study to show that people who use nonsteroidal anti-inflammatory drugs such as aspirin or ibuprofen for one year were less likely to have a heart attack or stroke," said Dr. David Shaughnessy, M. D., a professor of medicine at Harvard Medical School and director of the Massachusetts General Hospital Heart Institute.
A study published last year inthat found that the risk of having a heart attack or stroke increased in people who used NSAIDs for one year.
The risk of having a heart attack or stroke increased in people who used NSAIDs for one year
Dr. Gail Wilson said this study was published in the journaland was published online by a independent online journal.
"The risk of having a heart attack or stroke was already high in people who used NSAIDs for one year," said Dr. Gail Wilson, M. D., a professor of medicine at the University of Toronto and director of the Heart Institute, the American Heart Association, the British Heart Foundation, the American Thoracic Society and the American College of Clinical Oncology.
D., a professor of medicine at Harvard Medical School and director of the Massachusetts General Hospital Heart Institute, said this was the first study to show that the risk of having a heart attack or stroke increased in people who used NSAIDs for one year.
"It was the first study to show that people who used NSAIDs for one year had an increased risk of having a heart attack or stroke," said Dr. D., a professor of medicine at Harvard Medical School.
The study was funded by a British Heart Foundation, the Royal College of Surgeons of Great Britain and the British Thoracic Society.
This study was performed on the basis of a randomized trial (RCT) with a placebo group. The study included patients who had no symptoms of asthma (primary endpoint) and who were treated with a fixed dose of the drug naproxen sodium acetate (NAP-Ibuprofen) or a placebo. They were randomly assigned to one of two treatment arms, a control group who did not have any symptoms of asthma (group A), and a combination group who received both a fixed dose of naproxen sodium acetate (group B) and a placebo (group C). In both groups, the adverse effects were defined according to the formulary of the package insert for the product and the package insert for the product label.
In the two groups, patients were treated with the fixed dose of naproxen sodium acetate (NAP-Ibuprofen) or a fixed dose of naproxen sodium acetate (group A). The fixed dose of naproxen sodium acetate (NAP-Ibuprofen) was chosen because it is the most common oral medicine used in the United States for the treatment of osteoarthritis and rheumatoid arthritis in adults. The fixed dose of naproxen sodium acetate (NAP-Ibuprofen) was taken orally as an oral capsule and was administered with or without food. The fixed dose of naproxen sodium acetate (NAP-Ibuprofen) was taken once a day.
Naproxen sodium acetate and a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) were purchased from a pharmacy and were dispensed by the pharmacy.
The trial design was a randomized, double-blind, parallel group, double-dose, multicenter study. The study design included two RCTs with a total sample size of 12,000 patients. The first RCT was a fixed-dose study, which was followed by a randomized-dose study, which was followed by a placebo group. The second RCT included a fixed-dose study with a total sample size of 18,000 patients. In both studies, the investigators had to choose between two treatment arms, which were a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) or a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) for the first time. The trial was not allowed to include a control group in the first study, as this would be unethical. A study that compared the fixed dose of naproxen sodium acetate (NAP-Ibuprofen) and naproxen sodium acetate (NAP-Ibuprofen) for the first time in the same RCT was used to compare the treatment of patients with a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) and a placebo in the second RCT.
Patients in the treatment group received the fixed dose of naproxen sodium acetate (NAP-Ibuprofen) or a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) and were followed by the study in a double-blind, randomized, parallel group, double-dose, multicenter study. Patients were assigned to one of two treatment arms, which were a control group (group A) and a combination group (group B). They received a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) or a fixed dose of naproxen sodium acetate (NAP-Ibuprofen) for the first time.
₨5,000.00Original price was: ₨ 5,000.00.8,000.00
Ibuprofen 1% Gel is a nonsteroidal anti-inflammatory gel medicine used to treat pain and inflammation, particularly for the relief of symptoms associated with arthritis and other inflammatory conditions. It is commonly used to relieve pain associated with conditions such as headaches, dental pain, menstrual cramps, and muscle and joint discomfort. It works by reducing the production of prostaglandins, chemicals that cause pain and inflammation, providing relief from the pain, discomfort, and swelling experienced by individuals with conditions such as arthritis and pain.
Ideal for adults and children over 12, this product is clinically proven to provide effective relief from common back pain and menstrual cramps. It is suitable for use in children and adolescents under 12 years of age and is usually recommended for short-term use. It can also be used for over-the-counter topical pain relief products, as well as relieving minor aches and pain associated with common aches and pains.
Key Features:
Ibuprofen 1% Gel is indicated for the relief of pain, inflammation, and fever in conditions like:
Ibuprofen 1% Gel contains the active ingredient ibuprofen 1% that is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of certain chemical messengers in the body that cause pain and inflammation.
Ibuprofen Gel should be used with caution in patients with a history of allergic reactions to ibuprofen, aspirin, or other nonsteroidal anti-inflammatory drugs (NSAIDs).
Some common side effects of Ibuprofen Gel may include:
Ibuprofen Gel should not be used by individuals allergic to aspirin or other NSAIDs, or those with a history of asthma, hives, or skin reactions.
Individuals with a history of allergic reactions to other NSAIDs should avoid using this product.
It is important to tell a doctor about all the medications you are currently taking to make sure the drug is safe for you.
This product may cause stomach bleeding or ulcers. If you have any concerns about this, consult your doctor immediately.
This product should not be used during pregnancy, as it may harm an unborn baby. Before using this product, it is important to inform your doctor about any previous NSAID treatment, including heart problems or heart attacks. Ibuprofen Gel should not be used in children under 12 years of age.
It is important to keep your tablets out of the reach of children.
This product should not be used in pregnant or breastfeeding women.
This product should not be used during the last stages of pregnancy as it may harm an unborn baby. Consult your doctor before use in women who are pregnant or may become pregnant.
Each tablet contains ibuprofen 1% that is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, chemicals that cause pain and inflammation.
Stade de France Pharmacy